Clinical Trials Logo

Cerebral Palsy clinical trials

View clinical trials related to Cerebral Palsy.

Filter by:

NCT ID: NCT02645331 Completed - Clinical trials for Hemiplegic Cerebral Palsy

"Remind to Move" Treatment Versus Constraint-induced Movement Therapy for Children With Hemiplegic Cerebral Palsy

Start date: February 2013
Phase: N/A
Study type: Interventional

The aim of this study was to determine the effects of an innovative child-friendly remind-to-move treatment (RTM) treatment by comparing it with constraint-induced movement therapy (CIMT) on upper extremity outcomes in children with hemiplegic Cerebral Palsy. In an evaluator-blinded randomized controlled trial, 73 children, among of whom 20 in Manual Ability Classification System level I, 38 level II, and 15 level III, were recruited from 3 special schools and randomized to receive 75-hour RTM (n=25) and CIMT (n=24) programme over 15-weekdays, and conventional treatment (n=24). The primary outcomes were Jebsen-Taylor Hand Function Test (JTHFT) and Bruininks-Oseretsky Test of Motor Proficiency (BOTMP-II) Subtest 3 for assessing the motor efficiency at baseline, posttest, and 1- and 3-month follow-up.

NCT ID: NCT02643160 Completed - Clinical trials for Cerebral Palsy, Spastic

Analyzing the Effect of Trunk Training on Limbs in Children With Spastic Cerebral Palsy

FTT
Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze if trunk training has effects on trunk, upper, lower extremity motor functions in children with spastic Cerebral Palsy. Second purpose is to analyze the relation between trunk control and prematurity, birth weight, upper and lower extremity motor functions in children with spastic Cerebral Palsy.

NCT ID: NCT02637817 Recruiting - Cerebral Palsy Clinical Trials

MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates

PWML
Start date: January 2016
Phase:
Study type: Observational

As a common white matter (WM) disease in preterm neonates, punctate white matter lesion (PWML) frequently leads to the abnormalities of brain development (e.g. the motor, visual and auditory disorders), even to cerebral palsy (CP) and amblyopia during childhood. However, it is lack of certain methods in identifying the prognosis of PWML. Through using various advanced MRI techniques, neuro-behavioral and visual assessments, a multicenter longitudinal study would be conducted to follow-up the PWML neonates with varying spatial-position and degree lesions. Through tracking the variations in WM microstructures from neonate period to childhood (2 years old and 3 years old), this study aims to explore (1) the potential relations between varying PWMLs and motor and visual disorders (2) the relations between WM MRI-metrics and neurodevelopmental assessment results, and thus determine the early biomarkers to identify CP and amblyopia.

NCT ID: NCT02636205 Suspended - Cerebral Palsy Clinical Trials

The Use of Armeo Spring in Upper Extremity Rehabilitation

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the use of the Armeo®Spring Pediatric as therapy for children with hand and arm weakness. The Armeo®Spring Pediatric is a device that supports the weight of the child's arm and uses joystick that helps to play computer games. The child will be assessed before and after this therapy. Participating children with upper extremity impairments will receive therapy 3x/week for 6 weeks during 30-45 minutes sessions at progressively increasing degrees of difficulty. Each child's performance will be tracked with regard to time necessary to complete a predetermined number of trials of the activity. The standardized assessment tools that will be used are the Assisting Hand Assessment (AHA), Box & Blocks test, Jebsen Taylor hand function test, and the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Data will be analyzed to determine the efficacy of this training method.

NCT ID: NCT02633241 Completed - Epilepsy Clinical Trials

A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

Start date: March 2, 2017
Phase: Phase 4
Study type: Interventional

This is a pilot study to determine if a standard bolus dose and infusion of dexmedetomidine can significantly decrease the dose of propofol (infusion) required for accomplishing an MRI. The investigators studied three arms to examine the effectiveness of dexmedetomidine. Arm 1 was a single bolus of 1.0 mcg/kg with 1.0 mcg/kg/hr infusion followed by propofol infusion. Arm 2 was a bolus of 1.0 mcg/kg with 0.5 mcg/kg/hr infusion followed by propofol infusion. Arm 3 was only a single bolus of 1.0 mcg/kg with no infusion followed by propofol infusion.

NCT ID: NCT02621138 Not yet recruiting - Cerebral Palsy Clinical Trials

The Influence of Muscle Contraction on the Cardiac Autonomic System

Start date: April 2016
Phase: N/A
Study type: Observational

Population: 16 children with cerebral palsy, GMFCS 1-3.16 children typically developed, matched for age. All children aged 6-12 yrs who understand simple commands. Tools: 1. Polar monitor to record heart rate, attached to chest, in use throughout testing 2. Dynamometer- for assessing muscle strength. 3. Weights Method: Each child will be tested once. Both tools will be demonstrated and tried out before actual testing. With Polar watch attached: 1. 5 min sitting at rest, 2. knee muscle strength assessment with the dynamometer, 3. 15 minutes rest 4. Isometric and isotonic knee muscle contraction at 30% of childs` maximal strength as has assessed by the dynamometer. The child will asked to perform each for 3 minutes, with 5 minutes rest in-between All will be perform in both legs.

NCT ID: NCT02599207 Completed - Cerebral Palsy Clinical Trials

Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy

Start date: November 2015
Phase: Phase 1
Study type: Interventional

This study is a single site, phase I, prospective study of the safety of intravenous sibling cord blood infusion in 15 children ages 1-6 years with Cerebral Palsy (CP). All subjects will be treated with sibling cord blood cells. The first six will receive cord blood cells from an HLA-matched sibling. The following nine subjects will receive cord blood cells from an HLA-mismatched (≥3/6 match) or matched sibling. The duration of study participation will be six months from the time of the cord blood infusion.

NCT ID: NCT02599025 Not yet recruiting - Cerebral Palsy Clinical Trials

Effect of Posture and Passive Cycling on Cardiac Autonomic Control System in Children With Severe Cerebral Palsy

Start date: February 2016
Phase: N/A
Study type: Interventional

The investigators will examine the immediate contribution of position and movement on the functioning of the autonomic cardiac control system.

NCT ID: NCT02597374 Recruiting - Cerebral Palsy Clinical Trials

EEG in Children With Unilateral Cerebral Injury During Action and Action Observation(AOE)

AOE
Start date: October 2015
Phase: N/A
Study type: Interventional

To study the reactivity of the mu rhythm during action and action-observation by EEG in children with unilateral cerebral injury.

NCT ID: NCT02596412 Completed - Cerebral Palsy Clinical Trials

Augmented Reality to Reduce Pain During Botulinum Toxin Injections in Cerebral-palsied Children

MINIDOCS
Start date: December 1, 2015
Phase: N/A
Study type: Interventional

Children with cerebral palsy may benefit from treatment with botulinum toxin injections to decrease spasticity for improve function and quality of life. These injections cause repeated pain throughout childhood and may be the cause of post-traumatic stress despite drug and non-drug pain management. The Mini-Docs project of the French Red Cross has a module based on a digital device with augmented reality. Distracting the child, the use of this module on a tablet would reduce pain felt during botulinum toxin injections.